What can you expect?
The 14th Head & Neck Cancer symposium is focused on the diagnosis and treatment of locally advanced tumors.
Many recent developments, such as continuing epidemiological research, new insights in molecular biology, more understanding of the role of HPV, advances in 3D technology and the breakthrough of immunotherapy have changed the approach of head and neck cancer dramatically during the last decades.
These innovations may not only improve the outcome but also pose new challenges for multidisciplinary tumor boards in appropriate decision making.
This symposium brings pitfalls in implementation of these recent achievements in daily clinical practice to the attention of the participants. Lectures by keynote speakers will bring you up to date on general knowledge.
Who should attend?
The symposium is of importance for both residents and specialists working in the field of otolaryngology-head and neck surgery, oral and maxillofacial surgery, medical oncology, general surgery, radiotherapy, pathology, dermatology, radiology, speech and language pathology, fellows and residents in training.
· J Clark, Head and Neck Service, Chris O’Brien Lifehouse, Sydney, Australia
· RL Ferris, UPMC Hillman Cancer Center, Pittsburgh, USA
· VLM Vander Poorten, Department of Head and Neck Surgery, University Hospitals Leuven, Belgium
· RS Weber, Head and Neck Center, MD Anderson, Houston, USA
WH Schreuder, A Al-Mamgani, AJM Balm, JP de Boer, MWM van den Brekel, L Smit, CL Zuur
For more information on the program, venue and accommodation please check the website: